Overview
Shang-gin Wu practices in Taiwan. Wu is highly rated in 6 conditions, according to our data. Their top areas of expertise are EGFR Positive Lung Cancer, Lung Adenocarcinoma, Pleural Effusion, Lung Cancer, and Tissue Biopsy.
Their clinical research consists of co-authoring 56 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- EGFR Positive Lung CancerWu isDistinguished. Learn about EGFR Positive Lung Cancer.
- Lung AdenocarcinomaWu isDistinguished. Learn about Lung Adenocarcinoma.
- Pleural EffusionWu isDistinguished. Learn about Pleural Effusion.
- Advanced
- Lung CancerWu isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Tissue BiopsyWu isAdvanced. Learn about Tissue Biopsy.
- Experienced
- Inflammatory Myofibroblastic Tumor